Arbutus Biopharma Corporation
IPOHome - Arbutus Biopharma
Public · Burnaby, Canada · Founded 2015 · $116.0M raised
- Headquarters
- Burnaby
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- arbutusbio.com
- Total Funding
- $116.0M
- Last Round
- $116.0M Corporate RoundOct 2017
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Arbutus Biopharma (Nasdaq: ABUS) is a clinical-stage biopharmaceutical company focused on developing a functional cure for chronic hepatitis B virus (HBV) infection. Its pipeline includes RNAi therapeutics, immune modulators, and antivirals designed to be used in combination to suppress the virus and restore immune control in patients.
Summary
Arbutus Biopharma Corporation is a Biotech company based in Burnaby, Canada, founded in 2015. It has raised $116.0M in total across 1 round, most recently a $116.0M Corporate Round in Oct 2017. Investors include Roivant Sciences.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2017
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/arbutus-biopharma-corporation"><img src="https://indexed.vc/api/badge/company/arbutus-biopharma-corporation" alt="Arbutus Biopharma Corporation on Indexed.vc" width="260" height="76" /></a>